GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Applied DNA Sciences Inc (STU:UDJ) » Definitions » Price-to-Free-Cash-Flow

Applied DNA Sciences (STU:UDJ) Price-to-Free-Cash-Flow : N/A (As of May. 17, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Applied DNA Sciences Price-to-Free-Cash-Flow?

As of today (2024-05-17), Applied DNA Sciences's share price is €4.33. Applied DNA Sciences's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €-14.09. Hence, Applied DNA Sciences's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Applied DNA Sciences's Price-to-Free-Cash-Flow or its related term are showing as below:

STU:UDJ's Price-to-Free-Cash-Flow is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 27.33
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Applied DNA Sciences's Free Cash Flow per Share for the three months ended in Mar. 2024 was €-3.39. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was €-14.09.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 46.30% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 45.50% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 32.30% per year.

During the past 13 years, Applied DNA Sciences's highest 3-Year average Free Cash Flow per Share Growth Rate was 56.80% per year. The lowest was -11.50% per year. And the median was 21.00% per year.


Applied DNA Sciences Price-to-Free-Cash-Flow Historical Data

The historical data trend for Applied DNA Sciences's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied DNA Sciences Price-to-Free-Cash-Flow Chart

Applied DNA Sciences Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Applied DNA Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Applied DNA Sciences's Price-to-Free-Cash-Flow

For the Diagnostics & Research subindustry, Applied DNA Sciences's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Applied DNA Sciences's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Applied DNA Sciences's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Applied DNA Sciences's Price-to-Free-Cash-Flow falls into.



Applied DNA Sciences Price-to-Free-Cash-Flow Calculation

Applied DNA Sciences's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=4.33/-14.086
=N/A

Applied DNA Sciences's Share Price of today is €4.33.
Applied DNA Sciences's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-14.09.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Applied DNA Sciences  (STU:UDJ) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Applied DNA Sciences Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Applied DNA Sciences's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Applied DNA Sciences (STU:UDJ) Business Description

Traded in Other Exchanges
Address
50 Health Sciences Drive, Stony Brook, New York, NY, USA, 11790
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Applied DNA Sciences (STU:UDJ) Headlines

No Headlines